Wei-Yu Liao

Publication Activity (10 Years)

Years Active: 2021-2024
Publications (10 Years): 10

Top Topics

Tyrosine Kinase

Circulating Tumor

Chronic Myeloid Leukemia

Top Venues

Cancer medicine

JCO precision oncology

Therapeutic advances in medical oncology

APL bioengineering

This page only lists publications with an associated author ORCID identifier.

Publications

Hsin-Yi Wang, Chao-Chi Ho, Yen-Ting Lin, Wei-Yu Liao, Chung-Hsing Chen, Jin-Yuan Shih, Chong-Jen Yu
Comprehensive Genomic Analysis of Patients With Non-Small-Cell Lung Cancer Using Blood-Based Circulating Tumor DNA Assay: Findings From the BFAST Database of a Single Center in Taiwan. JCO precision oncology 8 (2024)
Hsin-Yi Wang, Chao-Chi Ho, Yen-Ting Lin, Wei-Yu Liao, Chung-Hsing Chen, Jin-Yuan Shih, Chong-Jen Yu
Comprehensive Genomic Analysis of Patients With Non-Small-Cell Lung Cancer Using Blood-Based Circulating Tumor DNA Assay: Findings From the BFAST Database of a Single Center in Taiwan. JCO precision oncology 8 (2024)
Hsin-Yi Wang, Chao-Chi Ho, Yen-Ting Lin, Wei-Yu Liao, Chung-Hsing Chen, Jin-Yuan Shih, Chong-Jen Yu
Comprehensive Genomic Analysis of Patients With Non-Small-Cell Lung Cancer Using Blood-Based Circulating Tumor DNA Assay: Findings From the BFAST Database of a Single Center in Taiwan. JCO precision oncology 8 (2024)
Huei-Jyuan Pan, Chia-Wei Lee, Li-Yu Wu, Heng-Hua Hsu, Yi-Chung Tung, Wei-Yu Liao, Chau-Hwang Lee
A 3D culture system for evaluating the combined effects of cisplatin and anti-fibrotic drugs on the growth and invasion of lung cancer cells co-cultured with fibroblasts. APL bioengineering 7 (1) (2023)
Yen-Ting Lin, Chao-Chi Ho, Wei-Hsun Hsu, Wei-Yu Liao, Ching-Yao Yang, Chong-Jen Yu, Tzu-Hsiu Tsai, James Chih-Hsin Yang, Shang-Gin Wu, Chia-Lin Hsu, Min-Shu Hsieh, Yen-Lin Huang, Chia-Ling Wu, Jin-Yuan Shih
Tissue or liquid rebiopsy? A prospective study for simultaneous tissue and liquid NGS after first-line EGFR inhibitor resistance in lung cancer. Cancer medicine (2023)
Yen-Ting Lin, Chao-Chi Ho, Wei-Hsun Hsu, Wei-Yu Liao, Ching-Yao Yang, Chong-Jen Yu, Tzu-Hsiu Tsai, James Chih-Hsin Yang, Shang-Gin Wu, Chia-Lin Hsu, Min-Shu Hsieh, Yen-Lin Huang, Chia-Ling Wu, Jin-Yuan Shih
Tissue or liquid rebiopsy? A prospective study for simultaneous tissue and liquid NGS after first-line EGFR inhibitor resistance in lung cancer. Cancer medicine 13 (1) (2023)
Yen-Ting Lin, Chao-Chi Ho, Wei-Hsun Hsu, Wei-Yu Liao, Ching-Yao Yang, Chong-Jen Yu, Tzu-Hsiu Tsai, James Chih-Hsin Yang, Shang-Gin Wu, Chia-Lin Hsu, Min-Shu Hsieh, Yen-Lin Huang, Chia-Ling Wu, Jin-Yuan Shih
Tissue or liquid rebiopsy? A prospective study for simultaneous tissue and liquid NGS after first-line EGFR inhibitor resistance in lung cancer. Cancer medicine (2023)
Yen-Ting Lin, Chao-Chi Ho, Wei-Hsun Hsu, Wei-Yu Liao, Ching-Yao Yang, Chong-Jen Yu, Tzu-Hsiu Tsai, James Chih-Hsin Yang, Shang-Gin Wu, Chia-Lin Hsu, Min-Shu Hsieh, Yen-Lin Huang, Chia-Ling Wu, Jin-Yuan Shih
Tissue or liquid rebiopsy? A prospective study for simultaneous tissue and liquid NGS after first-line EGFR inhibitor resistance in lung cancer. Cancer medicine (2023)
Chia-Ling Chang, Min-Shu Hsieh, Jin-Yuan Shih, Yi-Hsuan Lee, Wei-Yu Liao, Chia-Lin Hsu, Ching-Yao Yang, Kuan-Yu Chen, Jih-Hsiang Lee, Chao-Chi Ho, Tzu-Hsiu Tsai, James Chih-Hsin Yang, Chong-Jen Yu
Real-world treatment patterns and outcomes among patients with advanced non-small-cell lung cancer with spindle cell and/or giant cell carcinoma. Therapeutic advances in medical oncology 14 (2022)
Yen-Hsiang Huang, Jen-Yu Hung, How-Wen Ko, Po-Lan Su, Chun-Liang Lai, Huang-Chih Chang, Te-Chun Hsia, Sheng-Hao Lin, Kuan-Li Wu, Cheng-Ta Yang, Wu-Chou Su, Yi-Chun Chu, Chin-Chou Wang, Wei-Yu Liao, Yen-Ting Lin, Ching-Hsiung Lin, Meng-Chih Lin, Kuo-Hsuan Hsu, Jeng-Sen Tseng, Tsung-Ying Yang, Kun-Chieh Chen, Mei-Hsuan Lee, Sung-Liang Yu, Chao-Chi Ho, Gee-Chen Chang
The relative importance of predictive factors for single first-generation EGFR-TKI use for more than 5 years in patients with advanced non-small cell lung cancer: Taiwan multicenter TIPS-5 study. Therapeutic advances in medical oncology 13 (2021)